Stadtman E R
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.
Exp Gerontol. 1988;23(4-5):327-47. doi: 10.1016/0531-5565(88)90036-8.
It is the purpose of this report to identify possible metabolic deficiencies that might serve as biochemical markers of aging. It is proposed that the multiplicity of physical and physiological changes associated with aging could be most readily explained by alterations in the regulation and/or the activities of enzymes that occupy central positions in metabolism. Specifically, a search for metabolic markers of aging might include efforts to determine if there are age-related changes in the following enzymes or enzyme systems: (a) allosteric enzymes that catalyze reactions in highly branched metabolic pathways; (b) enzymes that catalyze opposing reactions between metabolites that are common intermediates in biosynthetic and biodegradative pathways (reactions which in the absence of final control would lead to futile substrate cycling); (c) enzymes that catalyze bimolecular reactions in which one member of a coenzyme pair is a cosubstrate (e.g., reactions involving NAD+ or NADH); (d) enzymes that are regulated by phosphorylation/dephosphorylation cycles; and (e) G-protein-dependent enzyme systems. It is also emphasized that changes in the concentrations and ratios of coenzyme substrate pairs (e.g., [NAD]/[NADH], [CoA]/[acyl CoA]) and the energy charge ratio [ATP] + 0.5 [ADP]/[ATP] + [ADP] + [AMP] may signal deviations from normal metabolism and therefore might be reliable markers of aging. In addition, because of their critical roles in metabolism, changes in the concentration of GTP, GDP and the second messengers, c-AMP, c-GMP should be monitored. Finally, it is noted that the accumulation of the altered forms of some enzymes which occurs during aging reflects imbalance between posttranslational modification of the enzymes and the degradation of the altered enzyme forms. The biological mechanisms involved and the genetic implications are discussed.
本报告旨在确定可能作为衰老生化标志物的潜在代谢缺陷。有人提出,与衰老相关的多种身体和生理变化最容易通过代谢中占据核心地位的酶的调节和/或活性改变来解释。具体而言,寻找衰老的代谢标志物可能包括努力确定以下酶或酶系统是否存在与年龄相关的变化:(a)催化高度分支代谢途径中反应的别构酶;(b)催化生物合成和生物降解途径中常见中间代谢物之间相反反应的酶(在没有最终控制的情况下,这些反应会导致无效的底物循环);(c)催化辅酶对中的一个成员作为共底物的双分子反应的酶(例如,涉及NAD+或NADH的反应);(d)受磷酸化/去磷酸化循环调节的酶;以及(e)G蛋白依赖性酶系统。还强调,辅酶底物对的浓度和比例变化(例如,[NAD]/[NADH]、[CoA]/[酰基辅酶A])以及能量电荷比[ATP]+0.5[ADP]/[ATP]+[ADP]+[AMP]可能表明偏离正常代谢,因此可能是可靠的衰老标志物。此外,由于它们在代谢中的关键作用,应监测GTP、GDP以及第二信使c-AMP、c-GMP的浓度变化。最后,值得注意的是,衰老过程中某些酶的改变形式的积累反映了酶的翻译后修饰与改变的酶形式的降解之间的不平衡。文中讨论了其中涉及的生物学机制及其遗传学意义。